Quick Takeaways
- ChemoCentryx, Inc. has 14 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are not currently available.
- Info
- Insider Trading
Insider Transactions Reported by 14 Insiders of ChemoCentryx, Inc.
- Location
- San Carlos, CA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 18 Apr 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
ChemoCentryx, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Vifor (International) Ltd | 10%+ Owner | $264,636,034 | Mixed | 12 Oct 2021 | ||
| Henry A. Mckinnell | Director | $3,706,525 | Mixed | 20 May 2022 | ||
| Joseph M. Feczko | Director | Mixed | 20 Oct 2022 | |||
| Rita Jain | EVP, Chief Medical Officer, Director | Mixed | 20 Oct 2022 | |||
| David E. Wheadon | Director | Mixed | 20 Oct 2022 | |||
| Susan M. Kanaya | EVP, Chief Financial and Administrative Officer, and Sec., Director | Mixed | 20 Oct 2022 | |||
| James L. Tyree | Director | Mixed | 20 Oct 2022 | |||
| Thomas J. Schall | President and CEO, Director | Mixed | 20 Oct 2022 | |||
| Markus J. Cappel | Chief Bus. Officer & Treasurer | Mixed | 20 Oct 2022 | |||
| Yi Ching Yau | SVP, Finance & Acctg Officer | Mixed | 07 Jun 2022 | |||
| Jennifer Lyn Herron | Director | Mixed | 20 Oct 2022 | |||
| Mr. Geoffrey Parker | Director | Mixed | 20 Oct 2022 | |||
| Tausif Butt | EVP, Chief Operating Officer | Mixed | 20 Oct 2022 | |||
| Thomas A. Edwards | Director | Mixed | 20 Oct 2022 |
Top shareholders of ChemoCentryx, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vifor (International) Ltd |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,194,085
|
$264,636,034 | — | 12 Oct 2021 | |
| Henry A. Mckinnell |
3/4/5
|
Director |
—
class O/S missing
|
72,749
|
$3,706,525 | — | 20 May 2022 | |
| Yi Ching Yau |
3/4/5
|
SVP, Finance & Acctg Officer |
—
class O/S missing
|
65,000
|
— | — | 07 Jun 2022 |
Recent Insider Transactions by Companies or Individuals for ChemoCentryx, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* An asterisk sign (*) next to the price indicates that the price is likely invalid.